David Busquets

1.6k total citations
28 papers, 481 citations indexed

About

David Busquets is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, David Busquets has authored 28 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Epidemiology and 12 papers in Genetics. Recurrent topics in David Busquets's work include Inflammatory Bowel Disease (12 papers), Gut microbiota and health (11 papers) and Microscopic Colitis (10 papers). David Busquets is often cited by papers focused on Inflammatory Bowel Disease (12 papers), Gut microbiota and health (11 papers) and Microscopic Colitis (10 papers). David Busquets collaborates with scholars based in Spain, United States and United Kingdom. David Busquets's co-authors include M Sàbat, Margarita Martínez-Medina, Xavier Aldeguer, Mireia López‐Siles, L. J. Garcia‐Gil, Sylvia H. Duncan, Harry J. Flint, C. A. Abella, Meritxell Casas and Esther Fort and has published in prestigious journals such as Gastroenterology, PLoS ONE and Applied and Environmental Microbiology.

In The Last Decade

David Busquets

27 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Busquets Spain	9	243	212	177	109	105	28	481
S. Peake United Kingdom	13	156 0.6×	164 0.8×	84 0.5×	86 0.8×	69 0.7×	36	556
Michael W. Bisset United Kingdom	3	174 0.7×	303 1.4×	193 1.1×	90 0.8×	122 1.2×	8	458
Jan Březina Czechia	6	214 0.9×	100 0.5×	141 0.8×	106 1.0×	118 1.1×	12	422
Lihi Godny Israel	11	112 0.5×	220 1.0×	111 0.6×	31 0.3×	99 0.9×	23	330
Laura H. Raffals United States	10	140 0.6×	181 0.9×	138 0.8×	63 0.6×	122 1.2×	45	400
M. Russel Netherlands	4	110 0.5×	236 1.1×	184 1.0×	32 0.3×	98 0.9×	9	386
Amir Abadir Canada	6	189 0.8×	237 1.1×	170 1.0×	107 1.0×	129 1.2×	8	447
Federica Ugolini Italy	11	150 0.6×	457 2.2×	275 1.6×	48 0.4×	265 2.5×	19	676
Cristiane C. Otoni United States	8	240 1.0×	51 0.2×	47 0.3×	115 1.1×	58 0.6×	10	455
J. Landy United Kingdom	9	160 0.7×	129 0.6×	112 0.6×	135 1.2×	75 0.7×	19	396

Countries citing papers authored by David Busquets

Since Specialization

Citations

This map shows the geographic impact of David Busquets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Busquets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Busquets more than expected).

Fields of papers citing papers by David Busquets

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Busquets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Busquets. The network helps show where David Busquets may publish in the future.

Co-authorship network of co-authors of David Busquets

This figure shows the co-authorship network connecting the top 25 collaborators of David Busquets. A scholar is included among the top collaborators of David Busquets based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Busquets. David Busquets is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Llirós, Marc, Robert Carreras‐Torres, Anna Feliu, et al.. (2024). Impact of bread diet on intestinal dysbiosis and irritable bowel syndrome symptoms in quiescent ulcerative colitis: A pilot study. PLoS ONE. 19(2). e0297836–e0297836. 5 indexed citations

Salazar, Juliana, Esther García-Planella, A Fernández-Clotet, et al.. (2024). Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registry. British Journal of Clinical Pharmacology. 90(5). 1301–1311. 3 indexed citations

Busquets, David, et al.. (2023). Lichen planus of the esophagus: a case report. Frontiers in Medicine. 10. 1233566–1233566. 1 indexed citations

López‐Siles, Mireia, Eva M. Gómez del Pulgar, M Sàbat, et al.. (2022). Prevalence, Abundance, and Virulence of Adherent-Invasive Escherichia coli in Ulcerative Colitis, Colorectal Cancer, and Coeliac Disease. Frontiers in Immunology. 13. 748839–748839. 20 indexed citations

Julià, David, et al.. (2022). Robotic modified Kono-S anastomosis after ileocecal resection for Crohn’s disease. Techniques in Coloproctology. 27(4). 335–335. 3 indexed citations

Busquets, David, Sara Ramió‐Pujol, M Sàbat, et al.. (2021). RAID Prediction: Pilot Study of Fecal Microbial Signature With Capacity to Predict Response to Anti-TNF Treatment. Inflammatory Bowel Diseases. 27(Supplement_2). S63–S66. 16 indexed citations

Ramió‐Pujol, Sara, et al.. (2021). A Novel Grape-Derived Prebiotic Selectively Enhances Abundance and Metabolic Activity of Butyrate-Producing Bacteria in Faecal Samples. Frontiers in Microbiology. 12. 639948–639948. 7 indexed citations

Marín‐Jiménez, Ignacio, Manuel Barreiro‐de Acosta, María Esteve, et al.. (2021). Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study. Gastroenterología y Hepatología. 45(3). 165–176. 4 indexed citations

Ramió‐Pujol, Sara, et al.. (2021). P686 Novel grape-derived prebiotic selectively enhances abundance and metabolic activity of IBD and IBS faecal butyrate producing bacteria in an in vitro model of intestinal fermentation. Journal of Crohn s and Colitis. 15(Supplement_1). S605–S606. 1 indexed citations

10.

Ramió‐Pujol, Sara, et al.. (2020). P848 A novel grape-derived prebiotic selectively enhances abundance and metabolic activity of butyrate producing bacteria in faecal samples of inflammatory bowel disease. Journal of Crohn s and Colitis. 14(Supplement_1). S653–S654. 1 indexed citations

11.

Albert, Marc, Esther Fort, David Busquets, et al.. (2020). A case report of gastrointestinal histoplasmosis in a patient treated with infliximab. Clinical Journal of Gastroenterology. 14(2). 690–692. 3 indexed citations

12.

Fernández-Clotet, A, Alejandro Hernández-Camba, Marisa Iborra, et al.. (2020). P462 Efficacy of ustekinumab for the prevention of postoperative recurrence in crohn’s disease. Data from clinical practice from the eneida registry. Journal of Crohn s and Colitis. 14(Supplement_1). S410–S410. 3 indexed citations

13.

Cabré, Eduard, Míriam Mañosa, Ignacio Marı́n, et al.. (2018). Characteristics of inflammatory bowel disease in patients of Roma/Gypsy ethnicity. A case-control study. Digestive and Liver Disease. 51(5). 669–674. 2 indexed citations

14.

Fernández‐Bañares, Fernando, Marta Piqueras, Danila Guagnozzi, et al.. (2017). Collagenous colitis: Requirement for high-dose budesonide as maintenance treatment. Digestive and Liver Disease. 49(9). 973–977. 7 indexed citations

15.

Taxonera, Carlos, Eva Iglesias, Fernándo Muñoz, et al.. (2016). Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation. Digestive Diseases and Sciences. 62(2). 481–490. 35 indexed citations

16.

Busquets, David, Mireia López‐Siles, Margarita Martínez-Medina, et al.. (2015). Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn’s Disease. Journal of Crohn s and Colitis. 9(10). 899–906. 61 indexed citations

17.

López‐Siles, Mireia, Margarita Martínez-Medina, C. A. Abella, et al.. (2015). Mucosa-Associated Faecalibacterium prausnitzii Phylotype Richness Is Reduced in Patients with Inflammatory Bowel Disease. Applied and Environmental Microbiology. 81(21). 7582–7592. 83 indexed citations

18.

López‐Siles, Mireia, Margarita Martínez-Medina, David Busquets, et al.. (2014). Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes. International Journal of Medical Microbiology. 304(3-4). 464–475. 109 indexed citations

19.

Casas, Meritxell, Josefina Móra, Esther Fort, et al.. (2007). Nutrición enteral total vs. nutrición parenteral total en pacientes con pancreatitis aguda grave. Revista Española de Enfermedades Digestivas. 99(5). 264–9. 51 indexed citations

20.

Roé, Esther, Josep Dalmau, Xavier García-Navarro, et al.. (2006). A Case of Vulvar Pyoderma Gangrenosum Associated with Collagenous Colitis. Dermatology. 213(3). 234–235. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact